195
Participants
Start Date
June 18, 2009
Primary Completion Date
February 18, 2011
Study Completion Date
February 18, 2011
Placebo
Part 1: Placebo SC administration every 2 weeks X 10 weeks.
ILV-094
Part 1: ILV-094 100 mg SC every 4 weeks (alternating ILV-094 100 mg and placebo every 2 weeks) X 10 weeks.
ILV-094
Part 1: ILV-094 100 mg SC every 2 weeks X 10 weeks.
Placebo
Part 2: Placebo SC administration every 2 weeks X 10 weeks
ILV-094
Part 2: ILV-094 200 mg SC every 2 weeks X 10 weeks
Budai Irgalmasrendi Hospital, Budapest
Obudai Egeszsegugyi Centrum Kft, Budapest
Cliniques Universitaires St Luc Avenue Hippocrate 10 UCL, Brussels
AZ Jan Palfijn, Antwerp
Reuma Instituut, Hasselt
Chu Liege Sart Tilman B 35, Liège
Josa Andras Oktatokorhaz Egeszsegugyi Szolgaltato Nonprofit Kft., Nyíregyháza
Universitair Ziekenhuis Gent, Ghent
Markusovszky Hospital, Szombathely
University Hospital Center Zagreb, Zagreb
Altoona Center for Clinical Research, Duncansville
Clinical Research Center of Reading, LLC, Wyomissing
Clinical Research Center of Reading, West Reading
Clinical Research Advantage, Inc., Sarasota
The Arthritis Specialty Centre, Sarasota
Arthritis Center, Palm Harbor
Centro de Estudio de Investigacion Basica y Clinica S.C, Jalisco
Deaconess Hospital, Cincinnati
Diagnostic Rheumatology and Research PC, Indianapolis
University Hospital Centre Rijeka, Rijeka
Clayton Medical Research, St Louis
Arthritis Care and Diagnostic Center, Dallas
Arthritis & Osteoporosis Center of South Texas, San Antonio
Klinikum Innenstadt der Ludwig-Maximillians-Universität, München
Arizona Arthritis & Rheumatology Research, PLLC, Glendale
Desert Medical Advances, Palm Desert
Institute of Rheumatology of Russian academy of Medical Scie, Moscow
City Clinical Hospital # 1 n.a. Pirogov, Moscow
State Healthcare Institution Yaroslavl Regional Clinical Hospital, Yaroslavl
State Educational Institution of Additional Professional Education, Saint Petersburg
State Health care institution of Leningrad Regional Clinical Hospital, Saint Petersburg
State education institution of higher vocational education Smolensk State Medical Academy Roszdrav, Smolensk
Centrul Medical Terra Med, Cluj-Napoca
Spitalul Clinic Judetean de Urgenta Tg Mures, Târgu Mureş
Municipal Institution City Clinical Hospital #40, Yekaterinburg
Centro de Reumatologia y Ortopedia, Barranquilla
Fundacion Instituto de Reumatologia Fernando Chalem, Bogota
Medicity S.A.S, Bucaramanga
Servimed EU, Bucaramanga
National Hospital Organization Shimoshizu National Hospital, Yotsukaidou
Gunma University Hospital, Maebashi
National Hospital Organization Sagamihara National Hospital, Sagamihara
Medical Corporation Wakoukai Kurashiki Kousai Hospital, Kurashiki
Institute of Rheumatology, Tokyo Women's Medical University Hospital, Shinjyuku-ku
Inoue Hospital, Gunma
Matsubara Clinic, Hyōgo
Matsubara Mayflower Hospital, Hyōgo
AMC, Amsterdam
SC Duo Medical SRL, Bucharest
Spitalul Clinic Sf. Maria, Bucharest
Spitalul Clinic Colentina, Bucharest
Centrul de Boli Reumatismale Dr. I. Stoia, Bucharest
Lead Sponsor
Pfizer
INDUSTRY